ReviewBMJ (Clinical research ed.)2002
Evaluating drug treatments for Parkinson's disease: how good are the trials?
Review in BMJ (Clinical research ed.), 2002. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Dopamine agonist therapy in early Parkinson's disease.The Cochrane database of systematic reviews · 2008Pooled it
- Article
- Stem Cell-based and Advanced Therapeutic Modalities for Parkinson's Disease: A Risk-effectiveness Patient-centered Analysis.Current neuropharmacology · 2022Review
- Optimizing levodopa therapy for Parkinson's disease with levodopa/carbidopa/entacapone: implications from a clinical and patient perspective.Neuropsychiatric disease and treatment · 2008Article
- Testing the SF-36 in Parkinson's disease. Implications for reporting rating scale data.Journal of neurology · 2008Article
- Impact of newer pharmacological treatments on quality of life in patients with Parkinson's disease.CNS drugs · 2008Review
- The 39 item Parkinson's disease questionnaire (PDQ-39) revisited: implications for evidence based medicine.Journal of neurology, neurosurgery, and psychiatry · 2007Article
- Funding evidence: the National Institute of Neurological Disorders and Stroke Clinical Trials Program.NeuroRx : the journal of the American Society for Experimental NeuroTherapeutics · 2004Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.